Browse All

Current Filters

CLEAR FILTER x

TITLE

Real-world Evidence on Treatment Retention, Safety, and Tolerability of Edaravone in Canadian Patients with Amyotrophic Lateral Sclerosis

Author:Pham, Dung   St-Onge, Louise   Ng, Ryan   Neish, Calum S.   Yap, Belinda   Kainth, Pinay   Apple, Stephen   

Session Name:P5: Neuromuscular and Clinical Neurophysiology (EMG): Amyotrophic Lateral Sclerosis 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P5.012  

Author Institution:Mitsubishi Tanabe Pharma Canada, Inc., Toronto, ON, Canada  IQVIA Solutions Canada, Inc., Mississauga, ON, Canada  Innomar Strategies, Oakville, ON, Canada  Mitsubishi Tanabe Pharma America, Inc., Jersey City, NJ  

Internet-supervised Home-based Spirometry Through Telemedicine in Amyotrophic Lateral Sclerosis

Author:Young, Eufrosina   Wang, Dongliang   Sah, Birendra   Manta, Dragos   Desai, Urvi   Slavinski, George   Deb, Lena   Posmik, Marielle   Kudou, Takuya   Patel, Kinjal   Apple, Stephen   Brooks, Benjamin   

Session Name:P6: Neuromuscular and Clinical Neurophysiology (EMG): Amyotrophic Lateral Sclerosis 2  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P6.013  

Author Institution:Upstate University Hospital, Syracuse, NY  Upstate Medical University, Syracuse, NY  Dept of Neurology, CMC, Charlotte, NC  Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan  Mitsubishi Tanabe Pharma America, New Jersey, NJ  Mitsubishi Tanabe Pharma America, Jersey City, NJ  Clinnical Trials Planning LLC, Charlotte, NC